Developmental Toxicology Division, Indian Institute of Toxicology Research (Formerly ITRC), CSIR, P.O. Box 80, M.G. Marg, Lucknow 226 001, U.P., India.
Drug Alcohol Depend. 2010 Jun 1;109(1-3):190-7. doi: 10.1016/j.drugalcdep.2010.01.010. Epub 2010 Feb 18.
The association of polymorphism of alcohol dehydrogenase (ADH) and its interaction with genes involved in the generation and detoxification of free radicals such as cytochrome P4502E1 (CYP2E1) and glutathione S-transferases M1 (GSTM1) were studied with alcoholic liver cirrhosis. The study included 175 alcoholic cirrhotic patients, 140 non-alcoholic cirrhotic patients, 255 non-alcoholic controls and 140 alcoholic controls. Our data revealed that the ADH1C*1/1 genotype exhibited significant association with alcoholic liver cirrhosis while ADH1B genotypes did not show any significant association. A much higher risk to alcoholic liver cirrhosis was observed in patients carrying a combination of wild genotypes of ADH1C (ADH1C1/1) and variant genotype of ADH1B (ADH1B2/2) or CYP2E1 (CYP2E15B) or null genotype of GSTM1. Our data suggest a role for the interaction amongst the genes involved in metabolizing alcohol and in generating and detoxifying free radicals with susceptibility to alcoholic liver cirrhosis.
研究了与酒精代谢和自由基生成与解毒有关的基因多态性及其相互作用与酒精性肝硬变的关系。该研究包括 175 例酒精性肝硬变患者、140 例非酒精性肝硬变患者、255 例非酒精性对照者和 140 例酒精性对照者。我们的数据表明,ADH1C*1/1 基因型与酒精性肝硬变显著相关,而 ADH1B 基因型则没有明显相关性。携带 ADH1C 野生基因型(ADH1C1/1)和 ADH1B 变异基因型(ADH1B2/2)或 CYP2E1(CYP2E15B)或 GSTM1 缺失基因型的患者患酒精性肝硬变的风险明显更高。我们的数据表明,与酒精代谢和自由基生成与解毒有关的基因之间的相互作用与酒精性肝硬变的易感性有关。